The American Journal of Surgery
Volume 192, Issue 5 , Pages e51-e54 , November 2006

Retrospective review of forefoot amputations at a Veterans Affairs hospital and evaluation of post-amputation follow-up

Presented at the 30th Annual Surgical Symposium of the Association of VA Surgeons, Cincinnati, Ohio, May 7–9, 2006

Received 5 May 2006 ,Revised 2 August 2006

References 

  1. Coldner M. The fate of the second leg in the diabetic amputee. Diabetes. 1960;9:100
  2. Hoar C, Torres L. Evaluation of below the knee amputation in the treatment of diabetic gangrene. N Engl J Med. 1962;266:440–443
  3. Eckman M, Greenfield S, Mackey W, et al. Foot infections in diabetic patients: decisions and cost-effective analysis. JAMA. 1995;273:712–720
  4. VHA PACT program directive. 2001;2001-030, May
  5. Holzeer SE, Camerota A, Martens L, et al. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther. 1998;20:169–181
  6. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382–387
  7. Gibbons GW, Marcarcio EJ, Burgess AM, et al. Improved quality of diabetic foot care. Arch Surg. 1993;128:576–581
  8. Runyan JW. The Memphis Chronic Disease Program: comparison in outcome and the nurses extended role. JAMA. 1975;231:264–267
  9. Wunderlich RP, Tredwell JL, Lavery LA. Reducing diabetes-related lower extremity hospitalizations in a disease management model. Diabetes (Program Book). 2001;A17
  10. Armstrong D. Is diabetic foot care efficacious or cost effective?. Ostomy Wound Manage. 2001;47:28–32
  11. Arias E. United States life tables 2002. Natl Vital Stat Rep. 2004;53:1–38
  12. Murdoch DP, Armstrong DG, Dacus JB, et al. The natural history of great toe amputations. J Foot Ankle Surg. 1997;36:204–208
  13. Armstrong DG, Harkless LB. Outcomes of preventative care in a diabetic foot specialty clinic. J Foot Ankle Surg. 1998;37:460–466
  14. Patout CA, Birke JA, Horswell R, et al. Effectiveness of a comprehensive diabetes lower-extremity amputation prevention program in a predominantly low-income African-American population. Diabetes Care. 2000;23:1339–1342
  15. Driver VR, Madsen J, Goodman RA. Reducing amputation rates in patients with diabetes at a military medical center. Diabetes Care. 2005;28:248–253
  16. Uccioli L, Faglia E, Monticone G, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care. 1995;18:1376–1378
  17. Chantelau E, Kushner T, Spraul M. How effective is cushioned therapeutic footwear in protecting diabetic foot?. Diabetic Med. 1990;7:355–359
  18. Quebedaux TL, Lavery DC, Lavery LA. The development of foot deformities and ulcers after great toe amputations in diabetics. Diabetes Care. 1996;19:165–167
  19. Viswanathan V, Madhavavan S, Gnanasundaram S, et al. Effectiveness of different types of footwear insoles for the diabetic neuropathic foot. Diabetes Care. 2004;27:474–477
  20. Reiber GE, Smith DG, Wallace C, et al. Two types of therapeutic footwear were no better than usual footwear for preventing foot re-ulceration. J Bone Joint Surg Am. 2002;84A:2107

PII: S0002-9610(06)00507-1

doi: 10.1016/j.amjsurg.2006.08.015

The American Journal of Surgery
Volume 192, Issue 5 , Pages e51-e54 , November 2006

Article Tools